$10K available
Peptides for Human Health
Offered by
ResearchHub Foundation
Submit Proposal
Submit Proposal
Details
Proposals
Updates
Fund
Fund
Search
Search
Ctrl+K
Publish
Home
Fund
Earn
Journal
Notebook
Lists
RSC
USD
About
Docs
Changelog
Terms
Privacy
Support
Best
No proposals found
Recent Activity
Peptides for Human Health
SB
Sagarika Banerjee
peer reviewed
4.0
Gut Microbiome–SCFA Axis as a Pharmacodynamic Modifier of GLP-1 Receptor Agonist Therapy in the South Asian Metabolic Phenotype
3 days ago
HS
Hafiz Syed Zaigham Ali Shah
peer reviewed
4.0
Gut Microbiome–SCFA Axis as a Pharmacodynamic Modifier of GLP-1 Receptor Agonist Therapy in the South Asian Metabolic Phenotype
5 days ago
IR
Ibrahim Rana
peer reviewed
5.0
Gut Microbiome–SCFA Axis as a Pharmacodynamic Modifier of GLP-1 Receptor Agonist Therapy in the South Asian Metabolic Phenotype
8 days ago
SB
Sagarika Banerjee
peer reviewed
4.0
Gut Microbiome–SCFA Axis as a Pharmacodynamic Modifier of GLP-1 Receptor Agonist Therapy in the South Asian Metabolic Phenotype
8 days ago
AM
Arshia Malek
Funded Proposal
+$202
Gut Microbiome–SCFA Axis as a Pharmacodynamic Modifier of GLP-1 Receptor Agonist Therapy in the South Asian Metabolic Phenotype
13 days ago
RF
ResearchHub Foundation
opened a bounty
Gut Microbiome–SCFA Axis as a Pharmacodynamic Modifier of GLP-1 Receptor Agonist Therapy in the South Asian Metabolic Phenotype
13 days ago
AM
Arshia Malek
Funded Proposal
+$205
Same Pathway as MOTS-c. Cheaper. Safer. The Brain-Body Imaging Data Just Doesn't Exist Yet
14 days ago
DW
David W
peer reviewed
4.0
Gut Microbiome–SCFA Axis as a Pharmacodynamic Modifier of GLP-1 Receptor Agonist Therapy in the South Asian Metabolic Phenotype
21 days ago
CL
Chieh-Te Lin
peer reviewed
3.0
Same Pathway as MOTS-c. Cheaper. Safer. The Brain-Body Imaging Data Just Doesn't Exist Yet
22 days ago
JM
José Mateus
peer reviewed
4.0
Same Pathway as MOTS-c. Cheaper. Safer. The Brain-Body Imaging Data Just Doesn't Exist Yet
22 days ago
IA
Ilhan Altinok
peer reviewed
4.0
Gut Microbiome–SCFA Axis as a Pharmacodynamic Modifier of GLP-1 Receptor Agonist Therapy in the South Asian Metabolic Phenotype
23 days ago
RG
Ramiro Alberto Cumbrera González
peer reviewed
4.0
Same Pathway as MOTS-c. Cheaper. Safer. The Brain-Body Imaging Data Just Doesn't Exist Yet
24 days ago
JM
José Mateus
peer reviewed
4.0
Gut Microbiome–SCFA Axis as a Pharmacodynamic Modifier of GLP-1 Receptor Agonist Therapy in the South Asian Metabolic Phenotype
25 days ago
SK
Shibichakravarthy Kannan
commented on
Gut Microbiome–SCFA Axis as a Pharmacodynamic Modifier of GLP-1 Receptor Agonist Therapy in the South Asian Metabolic Phenotype
a month ago
VB
Vanessa Bertolucci
peer reviewed
4.0
Gut Microbiome–SCFA Axis as a Pharmacodynamic Modifier of GLP-1 Receptor Agonist Therapy in the South Asian Metabolic Phenotype
a month ago